FibroGen Inc ( FGEN)Stock on triggering point now .
Target prices on Chart , where a Harmonic shap of anti 🦈
Buy it as much as you can now.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.4800 USD
−47.58 M USD
29.62 M USD
93.96 M
About FibroGen, Inc
Sector
Industry
CEO
Thane Wettig
Website
Headquarters
San Francisco
Founded
1993
FIGI
BBG000FW5ZL6
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.
FGEN Trade Setup for Monday!🔻 **Stop Loss (SL):** Below **0.5400**
📈 **Entry:** Above **0.5783**
🎯 **Target 1 (T1):** **0.6197**
🎯 **Target 2 (T2):** **0.6669**
💡 **Why Trade:**
Triangle breakout with bullish continuation and volume supporting the move.
✅ **Conclusion:**
Defined risk-reward; monitor breakout st
$FGENNot financial advice.
NASDAQ:FGEN
Scenario #1
weekly consolidation candles if it breaks to the upside it might fill the gap un purpple box, it can be an A,B,C.
Scenario #2
Breaks pennant triangle to the downside and it will revisit the lower part of the channel.
Like and follow.
FGEN, oversold with a good volumeI guess Fibrogen will announce they have a cure for a certain virus or disease. Let's see.
Not a financial advice.
FibroGen Has Great Technicals and FundamentalsI really like the technicals of this stock, we have nice over sold conditions with huge volume coming to accumulate. There is a huge gap above and I have set my targets on $6, $13 and $18 respectively. This is a larger time frame and potentially could take time to play out. I have attached an articl
FGEN A Biotechnology Penny running to earnings LONGFGEN has been uptrending for two weeks. In November's earnings it beat on revenue and
burned less cash than projected. Another earnings report is impending. On the 30 minute
chart, price has pumped 250%. The volume is okay but is not showing a rise and the price
volume trend is flat. This
FGEN - Free FallingTriple split screen analysis.
LEFT SCREEN:
FGEN broke support at $16.30 (white) and $9.20 (yellow) levels.
Currently it's at 47 cents and in what I refer to as, "no man's land."
It's "no man's land" because there's no support below it to keep price from falling further.
Could price reverse? Sure
FGEN Fibrogen Bottomed?Hi all.
Just an idea, not financial advice. :)
Looks like the FiboGen has reached its lowest level so far and to go 0 is not much left :)
seen the previous highs I think it is a good investment at the moment, with a low risk/high profit ratio in the long term, don't expect this to shoot up in a str
Up tnend startThe stock broke through resistance and went to close the gap. The global target is $24. Upside +50%. Trade with a trailing stop.
❤️ If you find this helpful and want more FREE forecasts in TradingView
. . . . . Please show your support back,
. . . . . . . . Hit the 👍 LIKE button,
. . . . . . . . .
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of FGEN is 0.2863 USD — it has increased by 3.13% in the past 24 hours. Watch FibroGen, Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange FibroGen, Inc stocks are traded under the ticker FGEN.
FGEN stock has risen by 10.12% compared to the previous week, the month change is a −23.98% fall, over the last year FibroGen, Inc has showed a −77.98% decrease.
We've gathered analysts' opinions on FibroGen, Inc future price: according to them, FGEN price has a max estimate of 10.00 USD and a min estimate of 10.00 USD. Watch FGEN chart and read a more detailed FibroGen, Inc stock forecast: see what analysts think of FibroGen, Inc and suggest that you do with its stocks.
FGEN reached its all-time high on Jul 9, 2018 with the price of 68.5500 USD, and its all-time low was 0.1800 USD and was reached on Nov 13, 2024. View more price dynamics on FGEN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
FGEN stock is 9.14% volatile and has beta coefficient of 0.70. Track FibroGen, Inc stock price on the chart and check out the list of the most volatile stocks — is FibroGen, Inc there?
Today FibroGen, Inc has the market capitalization of 28.01 M, it has increased by 12.67% over the last week.
Yes, you can track FibroGen, Inc financials in yearly and quarterly reports right on TradingView.
FibroGen, Inc is going to release the next earnings report on May 12, 2025. Keep track of upcoming events with our Earnings Calendar.
FGEN earnings for the last quarter are 0.18 USD per share, whereas the estimation was −0.14 USD resulting in a 228.57% surprise. The estimated earnings for the next quarter are 0.03 USD per share. See more details about FibroGen, Inc earnings.
FibroGen, Inc revenue for the last quarter amounts to 3.14 M USD, despite the estimated figure of 24.90 M USD. In the next quarter, revenue is expected to reach 1.60 M USD.
FGEN net income for the last quarter is 17.98 M USD, while the quarter before that showed −17.08 M USD of net income which accounts for 205.26% change. Track more FibroGen, Inc financial stats to get the full picture.
No, FGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 18, 2025, the company has 225 employees. See our rating of the largest employees — is FibroGen, Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FibroGen, Inc EBITDA is −43.75 M USD, and current EBITDA margin is −433.04%. See more stats in FibroGen, Inc financial statements.
Like other stocks, FGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FibroGen, Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FibroGen, Inc technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FibroGen, Inc stock shows the sell signal. See more of FibroGen, Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.